Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Magnus Buchus / Re: FutTheWuk / Re: opty / Re: Now I Understand How You And Some
9
Mar 15, 2011 12:58PM
11
Mar 15, 2011 05:11PM

<Since TPL gets money from PDS for both licensing efforts and from remaining profit distributions, and PTSC only gets it for the remaining profit distributions, TPL does benefit from the funding in a way that PTSC does not.>

Only if TPL receives more than actual costs. PTSC believes this to be the case, as does Moore, as does PTSC shareholders. It is why there is current litigation. The above assumes that nothing will be changed as a result of litigation. I hope you are wrong.

Opty

Share
New Message
Please login to post a reply